Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.
Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:
| (12) Patent Application: | (11) CA 3197311 |
|---|---|
| (54) English Title: | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF |
| (54) French Title: | COMPOSITIONS D'OLIGONUCLEOTIDES ET PROCEDES ASSOCIES |
| Status: | Application Compliant |
| (51) International Patent Classification (IPC): |
|
|---|---|
| (72) Inventors : |
|
| (73) Owners : |
|
| (71) Applicants : |
|
| (74) Agent: | BORDEN LADNER GERVAIS LLP |
| (74) Associate agent: | |
| (45) Issued: | |
| (86) PCT Filing Date: | 2021-11-08 |
| (87) Open to Public Inspection: | 2022-05-12 |
| Availability of licence: | N/A |
| Dedicated to the Public: | N/A |
| (25) Language of filing: | English |
| Patent Cooperation Treaty (PCT): | Yes |
|---|---|
| (86) PCT Filing Number: | PCT/US2021/058495 |
| (87) International Publication Number: | WO 2022099159 |
| (85) National Entry: | 2023-05-03 |
| (30) Application Priority Data: | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Among other things, the present disclosure provides oligonucleotides and compositions thereof. In some embodiments, provided oligonucleotides and compositions are useful for adenosine modification. In some embodiments, the present disclosure provides methods for treating various conditions, disorders or diseases that can benefit from adenosine modification.
La présente invention concerne entre autres des oligonucléotides et des compositions associées. Dans certains modes de réalisation, l'invention concerne des oligonucléotides et des compositions utiles pour la modification de l'adénosine. Dans certains modes de réalisation, la présente invention concerne des méthodes de traitement de divers états, troubles ou maladies qui peuvent tirer avantage d'une modification de l'adénosine.
Note: Claims are shown in the official language in which they were submitted.
Sorry, the claims for patent document number 3197311 were not found.
Text is not available for all patent documents. The current dates of coverage are on the
Currency of Information
page
Note: Descriptions are shown in the official language in which they were submitted.
Sorry, the description for patent document number 3197311 was not found. Text is not available for all patent documents. The current dates of coverage are on the Currency of Information page
Sorry, the representative drawing for patent document number 3197311 was not found.
2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.
Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.
For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee and Payment History should be consulted.
| Description | Date |
|---|---|
| Maintenance Request Received | 2024-11-01 |
| Maintenance Fee Payment Determined Compliant | 2024-11-01 |
| Compliance Requirements Determined Met | 2023-06-20 |
| Inactive: IPC assigned | 2023-06-02 |
| Inactive: IPC assigned | 2023-06-02 |
| Inactive: First IPC assigned | 2023-06-02 |
| Application Received - PCT | 2023-05-03 |
| National Entry Requirements Determined Compliant | 2023-05-03 |
| Request for Priority Received | 2023-05-03 |
| Request for Priority Received | 2023-05-03 |
| Letter sent | 2023-05-03 |
| Inactive: IPC assigned | 2023-05-03 |
| Request for Priority Received | 2023-05-03 |
| Request for Priority Received | 2023-05-03 |
| Request for Priority Received | 2023-05-03 |
| Application Published (Open to Public Inspection) | 2022-05-12 |
There is no abandonment history.
The last payment was received on
Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following
Please refer to the CIPO Patent Fees web page to see all current fee amounts.
| Fee Type | Anniversary Year | Due Date | Paid Date |
|---|---|---|---|
| Basic national fee - standard | 2023-05-03 | ||
| MF (application, 2nd anniv.) - standard | 02 | 2023-11-08 | 2023-11-03 |
| MF (application, 3rd anniv.) - standard | 03 | 2024-11-08 | 2024-11-01 |
| MF (application, 3rd anniv.) - standard | 03 | 2024-11-08 |
Note: Records showing the ownership history in alphabetical order.
| Current Owners on Record |
|---|
| WAVE LIFE SCIENCES LTD. |
| Past Owners on Record |
|---|
| ANDREW GUZIOR HOSS |
| ANTHONY LAMATTINA |
| CHANDRA VARGEESE |
| CHIKDU SHAKTI SHIVALILA |
| DAVID CHARLES DONNELL BUTLER |
| DAVID JOHN BOULAY |
| GENLIANG LU |
| HAILIN YANG |
| HUI YU |
| JACK DAVID GODFREY |
| JAYAKANTHAN KUMARASAMY |
| JIGAR DESAI |
| LUCIANO HENRIQUE APPONI |
| MAMORU SHIMIZU |
| NAOKI IWAMOTO |
| PACHAMUTHU KANDASAMY |
| PRASHANT MONIAN |
| STEPHANY MICHELLE STANDLEY |
| SUBRAMANIAN MARAPPAN |
| TOM LIANTANG PU |
